FI105270B - Menetelmä terapeuttisesti käyttökelpoisten oktahydro-1H-1-pyrindiini-4,5,6,7-terolien valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten oktahydro-1H-1-pyrindiini-4,5,6,7-terolien valmistamiseksi Download PDFInfo
- Publication number
- FI105270B FI105270B FI941259A FI941259A FI105270B FI 105270 B FI105270 B FI 105270B FI 941259 A FI941259 A FI 941259A FI 941259 A FI941259 A FI 941259A FI 105270 B FI105270 B FI 105270B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- compound
- octahydro
- hydrogen
- bno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76157991A | 1991-09-18 | 1991-09-18 | |
US76157991 | 1991-09-18 | ||
US07/893,171 US5262425A (en) | 1991-09-18 | 1992-06-03 | α-mannosidase inhibitors |
US89317192 | 1992-06-03 | ||
US9206707 | 1992-08-10 | ||
PCT/US1992/006707 WO1993005781A1 (en) | 1991-09-18 | 1992-08-10 | Novel alpha-mannosidase inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
FI941259A0 FI941259A0 (fi) | 1994-03-17 |
FI941259A FI941259A (fi) | 1994-03-17 |
FI105270B true FI105270B (fi) | 2000-07-14 |
Family
ID=27117010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI941259A FI105270B (fi) | 1991-09-18 | 1994-03-17 | Menetelmä terapeuttisesti käyttökelpoisten oktahydro-1H-1-pyrindiini-4,5,6,7-terolien valmistamiseksi |
Country Status (15)
Country | Link |
---|---|
US (1) | US5262425A (ja) |
EP (1) | EP0641327B1 (ja) |
JP (1) | JP3226173B2 (ja) |
KR (1) | KR100244012B1 (ja) |
AT (1) | ATE175960T1 (ja) |
AU (1) | AU659486B2 (ja) |
CA (1) | CA2116224C (ja) |
DE (1) | DE69228259T2 (ja) |
DK (1) | DK0641327T3 (ja) |
ES (1) | ES2127758T3 (ja) |
FI (1) | FI105270B (ja) |
GR (1) | GR3029745T3 (ja) |
HU (1) | HU216789B (ja) |
NO (1) | NO300372B1 (ja) |
WO (1) | WO1993005781A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773239A (en) * | 1993-10-19 | 1998-06-30 | Mount Sinai Hospital Corporation. | Mannosidase inhibitors, process for their preparation and their use as therapeutic agents |
US5650413A (en) * | 1995-06-07 | 1997-07-22 | Glycodesign Inc. | Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents |
CA2267412A1 (en) * | 1996-10-01 | 1998-04-09 | Glycodesign Inc. | Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
CA2286766A1 (en) | 1997-04-15 | 1998-10-22 | Glycodesign Inc. | Alkaloid halide salts of swainsonine and methods of use |
US6245316B1 (en) | 1997-10-08 | 2001-06-12 | David Platt | Enhancement of delivery of radioimaging and radioprotective agents |
CA2307595A1 (en) * | 1997-10-24 | 1999-05-06 | Glycodesign Inc. | Synthesis of swainsonine salts |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4031102A (en) * | 1972-10-21 | 1977-06-21 | John Wyeth & Brother Limited | Cyclopenteno[b]pyridine derivatives |
GB2088860B (en) * | 1980-12-09 | 1984-05-23 | Wyeth John & Brother Ltd | Process for preparing ring-fused pyridine derivatives |
-
1992
- 1992-06-03 US US07/893,171 patent/US5262425A/en not_active Expired - Fee Related
- 1992-08-10 CA CA002116224A patent/CA2116224C/en not_active Expired - Fee Related
- 1992-08-10 KR KR1019940700863A patent/KR100244012B1/ko not_active IP Right Cessation
- 1992-08-10 EP EP92918131A patent/EP0641327B1/en not_active Expired - Lifetime
- 1992-08-10 DE DE69228259T patent/DE69228259T2/de not_active Expired - Fee Related
- 1992-08-10 ES ES92918131T patent/ES2127758T3/es not_active Expired - Lifetime
- 1992-08-10 DK DK92918131T patent/DK0641327T3/da active
- 1992-08-10 JP JP50602793A patent/JP3226173B2/ja not_active Expired - Fee Related
- 1992-08-10 WO PCT/US1992/006707 patent/WO1993005781A1/en active IP Right Grant
- 1992-08-10 AU AU24771/92A patent/AU659486B2/en not_active Ceased
- 1992-08-10 AT AT92918131T patent/ATE175960T1/de not_active IP Right Cessation
- 1992-08-10 HU HU9400787A patent/HU216789B/hu not_active IP Right Cessation
-
1994
- 1994-03-17 FI FI941259A patent/FI105270B/fi active
- 1994-03-17 NO NO940972A patent/NO300372B1/no unknown
-
1999
- 1999-03-19 GR GR990400830T patent/GR3029745T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE175960T1 (de) | 1999-02-15 |
EP0641327B1 (en) | 1999-01-20 |
WO1993005781A1 (en) | 1993-04-01 |
CA2116224A1 (en) | 1993-04-01 |
KR100244012B1 (ko) | 2000-03-02 |
HUT70527A (en) | 1995-10-30 |
DK0641327T3 (da) | 1999-09-13 |
US5262425A (en) | 1993-11-16 |
HU9400787D0 (en) | 1994-06-28 |
DE69228259D1 (de) | 1999-03-04 |
NO300372B1 (no) | 1997-05-20 |
NO940972L (no) | 1994-03-17 |
GR3029745T3 (en) | 1999-06-30 |
EP0641327A1 (en) | 1995-03-08 |
EP0641327A4 (en) | 1994-06-01 |
AU659486B2 (en) | 1995-05-18 |
AU2477192A (en) | 1993-04-27 |
FI941259A0 (fi) | 1994-03-17 |
JPH06510785A (ja) | 1994-12-01 |
JP3226173B2 (ja) | 2001-11-05 |
CA2116224C (en) | 2003-06-03 |
DE69228259T2 (de) | 1999-06-02 |
HU216789B (hu) | 1999-08-30 |
ES2127758T3 (es) | 1999-05-01 |
FI941259A (fi) | 1994-03-17 |
NO940972D0 (no) | 1994-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0708085B1 (en) | Antiviral ethers of aspartate protease substrate isosteres | |
US10294246B2 (en) | Substituted boronic acids and boronate esters as immunoproteasome inhibitors | |
EA005817B1 (ru) | Производные гексагидро-7-1h-азепин-2-илгексановой (или гексеновой) кислоты в качестве ингибиторов индуцибельной синтазы оксида азота | |
CA2903483A1 (en) | Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders | |
US8258321B2 (en) | Beta-lactone compounds | |
KR20190129968A (ko) | 기생충성 질환의 치료를 위한 화합물 및 방법 | |
JP2021531310A (ja) | ボロン酸誘導体 | |
FI105270B (fi) | Menetelmä terapeuttisesti käyttökelpoisten oktahydro-1H-1-pyrindiini-4,5,6,7-terolien valmistamiseksi | |
US11434198B2 (en) | Compounds and methods for the treatment of neurodegenerative diseases | |
KR100894237B1 (ko) | 항미생물제로서의엔-설포닐-4-메틸렌아미노-3-하이드록시-2-피리돈 | |
MXPA06000294A (es) | Compuestos que tienen actividad contra el virus de la hepatitis c y procedimiento para producirlo. | |
US10464883B2 (en) | Compounds and methods for the treatment of neurodegenerative diseases | |
EP3353163B1 (en) | 2,3,4,5-tetrahydropyridin-6-amine derivatives | |
US20220144836A1 (en) | Novel synthetic options towards the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-one | |
CA2040058C (en) | Alpha-mannosidase and fucosidase inhibitors | |
US5240707A (en) | Alpha-mannosidase and fucosidase inhibitors | |
KR20220139752A (ko) | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 싸이오카보닐 화합물 및 이를 포함하는 약제학적 조성물 | |
JP2009520813A (ja) | カルバメート系抗生物質 | |
EP1387841A1 (fr) | Nouveaux derives d'azole ou de triazole, leur procede de preparation et leur application comme fongicides | |
KR101881115B1 (ko) | 신규 2-치환된 테트라하이드로피란 또는 2-치환된 테트라하이드로퓨란 유도체 화합물, 이의 제조방법 및 이의 용도 | |
CA3102497A1 (en) | Open-ring fatty acid compound having anti-cancer activity | |
RU2780118C2 (ru) | Производные иминомочевины | |
EP0949238A1 (en) | Substituted propionyl derivatives | |
WO1998042700A1 (fr) | Derives de n-(arginyl)benzenesulfonamide et leur utilisation comme agents antithrombotiques | |
WO2022040788A1 (en) | Open-ring and lactone derivatives of unsaturated trihydroxy c-18 fatty acids and pharmaceutical compositions thereof having anti-cancer activity |